Lower pretreatment CD@ % and higher HIV-@ RNA levels were associated with reduced efficacy , lower pretreatment CD@ % with shorter time to ART discontinuation because of a protocol-defined toxicity , and no PrNVP with shorter time to first grade @ adverse event .